BTIG analyst David Larsen upgraded Progyny (PGNY) to Buy from Neutral with a $28 price target
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGNY:
- Progyny launches Parent and Child Well-being Offering
- Progyny’s Promising Growth Amidst Uncertainty: Hold Rating Maintained
- Progyny, Inc. Reports Strong 2024 Earnings with Optimistic Outlook
- Progyny’s Strong Q4 Results Amid Competitive Challenges and Uncertain Demand: Hold Rating Maintained
- Progyny price target raised to $34 from $30 at BofA